N@N

ACOR, TAM, JWF, UCTT, CYTK, CAMT Are Seasonally Ripe To Go Down In the Next Five Weeks

March 12, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ACORDA THERAPEUTICS INC (NASDAQ:ACOR), Tam SA (NYSE:TAM), Wells Fargo Capital IX (NYSE:JWF), ULTRA CLEAN HOLDINGS (NASDAQ:UCTT), CYTOKINETICS INC (NASDAQ:CYTK), Camtek Ltd (NASDAQ:CAMT) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  ACOR    ACORDA THERAPEUTICS INC          -2.70%           100.00% (6 of 6)     Tuesday, March 13th 2012
  TAM     Tam SA                           -1.40%           100.00% (6 of 6)     Tuesday, March 13th 2012
  JWF     Wells Fargo Capital IX           -1.76%           85.71% (6 of 7)      Wednesday, March 14th 2012
  UCTT    ULTRA CLEAN HOLDINGS             -2.94%           85.71% (6 of 7)      Wednesday, March 14th 2012
  CYTK    CYTOKINETICS INC                 -4.69%           85.71% (6 of 7)      Tuesday, March 13th 2012
  CAMT    Camtek Ltd                       -3.89%           100.00% (11 of 11)   Monday, March 19th 2012

ACORDA THERAPEUTICS INC (NASDAQ:ACOR) - Acorda Therapeutics, Inc., a biotechnology company, develops therapies for multiple sclerosis, spinal cord injury, and other nervous system disorders. Its marketed products include Ampyra (dalfampridine), a potassium channel blocker for improving walking in patients with multiple sclerosis; and Zanaflex Capsules and Zanaflex tablets (tizanidine hydrochloride), a short-acting drug for the management of spasticity. The companys pipeline also includes various products in development for the treatment, regeneration, and repair of the spinal cord and brain. Its preclinical products comprise remyelination programs that include two distinct therapeutic approaches to stimulate repair of the damaged myelin sheath in multiple sclerosis, neuregulins/glial growth factor 2, and remyelinating antibodies; and chondroitinase program, which develops second generation approaches to overcoming the proteoglycan matrix. Acorda Therapeutics sells its products through specialty sales force, managed care team, and contract pharmaceutical telesales organizations. The company was founded in 1995 and is based in Hawthorne, New York.

Tam SA (NYSE:TAM) - TAM S.A., through its subsidiaries, provides passenger and cargo air transportation services in Brazil and internationally. The company also engages in aircraft sub-leasing, as well as aircraft acquisition, financing, and debt issuance activities. In addition, it provides aircraft maintenance, and travel and tourism agency services; and offers customer loyalty programs. The company operates a fleet of approximately 148 operational aircrafts. TAM was founded in 1961 and is based in Sao Paulo, Brazil.

Wells Fargo Capital IX (NYSE:JWF) - Wells Fargo Ix

ULTRA CLEAN HOLDINGS (NASDAQ:UCTT) - Ultra Clean Holdings, Inc. develops and supplies critical subsystems to the original equipment manufacturers of semiconductor capital equipment in North America, Europe, and Asia. The companys products include gas delivery systems, which control the flow, pressure, sequencing, and mixing of specialty gases into and out of the reaction chambers of semiconductor manufacturing tools; chemical mechanical planarization subsystems; and chemical delivery modules that deliver gases and reactive chemicals from a centralized subsystem to the reaction chamber, as well as gas delivery systems, and liquid and vapor delivery systems. It also offers top-plate assemblies that form the top portion of the reaction chamber, within which gases controlled by gas delivery systems react to form thin films or etch films on the wafer; frame assemblies that form the support structure, to which various other assemblies are attached; and pneumatic harnesses and cables that connect other critical subsystems. In addition, the company provides process modules that comprise frame assembly, top-plate assembly, and gas and chemical delivery modules, as well as the chamber and electronic, pneumatic, and mechanical subsystems; and other high level assemblies, which are used in semiconductor manufacturing, research, flat panel, energy, and medical equipment industries. Ultra Clean Holdings, Inc. was founded in 1991 and is headquartered in Hayward, California.

CYTOKINETICS INC (NASDAQ:CYTK) - Cytokinetics, Incorporated, a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. It primarily offers omecamtiv mecarbil, a cardiac muscle myosin activator, which is in Phase I/IIa clinical trials for the treatment of heart failure; CK-2017357, which is a Phase IIa clinical trials for the treatment of amyotrophic lateral sclerosis; and CK-2066260, a fast skeletal muscle sarcomere activator for the treatment of diseases and conditions associated with muscle weakness or wasting. The companys cancer treatment products under development stage comprise ispinesib, SB-743921, and GSK-923295. It has a strategic alliance with Amgen Inc. to discover, develop, and commercialize novel small molecule therapeutics that activate cardiac muscle contractility for applications in the treatment of heart failure. The company was founded in 1997 and is headquartered in South San Francisco, California.

Camtek Ltd (NASDAQ:CAMT) - Camtek Ltd., incorporate in 1987, designs, develops, manufactures and markets automated optical inspection (AOI) systems and related products. AOI systems are computerized systems, which optically inspect electronic product components for defects caused during the manufacturing process. The Company's AOI systems are used to enhance both production processes and yields for manufacturers in three industries: the printed circuit board (PCB) industry, the high-density interconnect (HDI-S) industry, and the semiconductor manufacturing and packaging industry. Camtek's system provides its customers the level of defect detection. The Company sold more than 1,600 of its AOI systems in over 30 countries around the world, predominantly to the PCB industry. Its customer base includes 100 PCB manufacturers worldwide. Its global direct customer support network provides responsive, localized support for its installed base.

The Company's products incorporate its own advanced image processing software and algorithms, as well as advanced electro-optics and precision mechanics. In addition, its AOI systems use technology that enables its customers to handle a range of inspection and verification needs. The Company's AOI systems consist of a precise, movable table; an electro-optical assembly unit, either movable or fixed, which consists of a video camera, precision optics and illumination sources, and an electronic hardware unit, which operates the entire system and includes embedded components that process and analyze the captured image by using the Company's algorithms.

Automated Optical Inspection Systems for the PCB and High-Density Interconnect Substrate Industries.

Camtek's products for these industries consist of the Dragon and Orion lines for the inspection of inner and outer layers of PCB panels; the Pegasus line for inspection of HDI-S, and special models dedicated for inspection of artwork and photo masks. Dragon systems are high-throughput, automation-ready systems for inspection of PCB's for a mass production environment. Dragon models are designed to interface with automated material handling mechanisms. Orion systems are stand-alone AOI systems for high-volume inspection of PCB's. Orion models retain an ergonomic user interface that supports high productivity and flexibility allowing successive online inspection and verification or offline verification on a separate station.

The Pegasus product line includes systems for automated inspection of finished organic substrates that are used in packaging of ball grid array and chip scale package devices. The Pegasus inspects both sides of the substrate, searching for process and mechanical defects in particular in the gold-plated areas where the substrate will interconnect with the silicon die or the PCB. Pegasus models handle substrates in strip format in magazines or singular substrates in trays. The Automated Inspectify Center (AIC) integrates inspection and verification into one cell that maximizes productivity across the entire AOI operation. Through its pickup and transfer mechanism, the AIC bridges between the Dragon and Camtek's verification station, CVR-200.

Automated Optical Inspection Systems for the Semiconductor Industry.

Falcon products integrate two-dimensional and three-dimensional inspection, metrology and analysis capabilities on a single platform. These capabilities enable Falcon to detect defects in the semiconductor die, which helps in reducing causes in premature failures. In addition, inspection data can be used by customers to monitor and characterize several wafer finishing processes, troubleshoot electrical testing issues or control the integrity of the interconnect bump arrays made on dice intended for packaging in flip chip technology. The Falcon family includes models for three-dimensional (3D) and two-dimensional (2D) metrology of bumped-wafer prepared for packaging in the flip-chip technology; inspection of finished wafers at the end of their manufacturing process and in test houses.

Camtek Ltd. competes with Dainippon Screen, Or

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641